Latest Partnerships News

Page 16 of 746
Locality Planning Energy has signed a 15-year energy services agreement with Walker Corporation for its SOL development in Maroochydore. The contract expands LPE’s property developer network, but revenue and infrastructure costs remain undisclosed and will build progressively from late 2027.
Victor Sage
Victor Sage
21 Oct 2026
First Graphene reported unaudited first-quarter income of about A$201,000, up 21% year on year, as PureGRAPH moved into new cement, mining, composites and footwear applications. The commercial pipeline expanded, but A$915,000 of operating cash outflow left the company with A$1.831 million and an estimated two quarters of funding at the reported burn rate.
Victor Sage
Victor Sage
20 Oct 2026
Brazilian Rare Earths has strengthened the development case for its Brazilian rare earths portfolio, reporting high-grade Monte Alto drilling, a new Sulista discovery and first concentrate production at Camaçari. The company ended September with A$121.8 million in cash and no borrowings, although its headline US$6.0 billion project valuation remains based on a preliminary study with substantial inferred resources.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Aquirian has secured an approximately $21 million, three-year extension to supply technology and energetics at the Mt Ida Gold Project. The deal requires no additional capital expenditure and extends the supply term to December 2030.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Blackpearl Group narrowed its quarterly EBITDAF loss to $2.97 million and is now targeting profitability in Q1 FY28. The company has also secured a non-binding US distribution agreement with a potential pipeline of more than 70 enterprise customers.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Actinogen Medical says its pivotal XanaMIA Alzheimer’s trial remains on course for topline results in November after the final patient visit was completed. The company also reported $15.9 million in cash, a further $5.3 million from option funding and a projected runway into late 2027 or 2028, assuming future trials are substantially partner-funded.
Ada Torres
Ada Torres
19 Oct 2026
Provaris Energy’s share purchase plan attracted preliminary applications of $755,000, exceeding its $600,000 target. The company will accept the oversubscription, with the final amount, issue price and share allocation due on 21 October.
Maxwell Dee
Maxwell Dee
19 Oct 2026
Acrux has received clearer FDA guidance for Phase III trials of its female testosterone spray, including potential three-year data exclusivity if the product reaches submission. The company also reported positive September-quarter operating cash flow, but that result was largely driven by a $1.977 million R&D tax rebate and Acrux says it is still pursuing funding for the clinical programme.
Victor Sage
Victor Sage
19 Oct 2026
Stockland has maintained its FY27 earnings, distribution and settlement targets despite softer residential demand and longer customer decision times. Logistics and retail remain firm, while the group’s data centre pipeline now has approximately 450MW of power secured.
Eva Park
Eva Park
19 Oct 2026
Algorae has secured exclusive Australian commercial rights across eight Umedica-branded molecules while separately advancing a Umedica-supplied product towards regulatory approval. The broader arrangement remains partly non-binding, with financial terms undisclosed and TGA approval still pending.
Victor Sage
Victor Sage
19 Oct 2026
MONEYME opened FY27 with stronger growth, record-low net credit losses and its third consecutive quarter of positive Normalised NPAT. The unaudited result supports the lender’s reaffirmed FY27 target of breakeven to $7 million, while its expanding unsecured portfolio remains an important test.
Claire Turing
Claire Turing
19 Oct 2026
Bendigo Bank’s unaudited 1Q27 cash earnings rose 18.5% against the prior half-year quarterly average, but statutory profit fell as net interest margin narrowed and non-cash property revaluations weighed. Deposits grew while lending contracted, with the bank continuing its costly non-financial risk remediation program.
Victor Sage
Victor Sage
19 Oct 2026

Browse the archive

Full archive